Tuesday, January 08, 2019 5:03:49 PM
Around one-fifth of the office’s workforce will focus on creating more structured approaches to the evaluation of biomarkers, which Gottlieb thinks are ready to play a “much more formal” role in drug development and review. One strand of the biomarker unit’s activities will seek to develop standards in collaboration with drug developers, academics and other stakeholders.
Another third of the office’s 51 employees will work on biomedical informatics and safety analytics. Gottlieb said these staff will build “a standardized tool for capturing and formatting safety data” to make the agency’s reviews of safety data more structured and consistent.
If the initiative advances as hoped, it will serve as a stepping stone to a new way of managing drug application reviews. The new approach foreseen by Gottlieb will build on advances in data handling and cloud computing to give the FDA a more active role in how the information underpinning filings is presented and evaluated.
“Applications will be cloud based and instead of taking the sponsors' charts and tables and evaluating their charts and tables, we’ll be pulling down their bottom line data and formatting it through our own assessment tools and creating our own charts and tables to do the evaluation,” Gottlieb said.
Recent KNW News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/24/2024 09:00:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 09:23:58 PM
- Know Labs Study Published in IEEE Sensors Journal • Business Wire • 09/10/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 01:25:14 PM
- Know Labs, Inc. Announces $1.655 Million Public Offering • Business Wire • 08/16/2024 01:16:00 PM
- Know Labs, Inc. Reports Third Quarter FY 2024 Results • Business Wire • 08/14/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 10:01:40 AM
- Know Labs, Inc. Announces Closing of $3.445 Million Public Offering • Business Wire • 08/12/2024 10:38:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/12/2024 09:00:15 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/08/2024 04:15:14 AM
- Know Labs, Inc. Announces Pricing of $3.445 Million Public Offering • Business Wire • 08/08/2024 12:50:00 AM
- Know Labs, Inc. to Host Review of Third Quarter Fiscal Year 2024 Results on August 14, 2024 • Business Wire • 08/06/2024 01:00:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/02/2024 08:15:55 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/25/2024 01:49:42 AM
- Know Labs Publishes Clinical Results in Leading Diabetes Journal • Business Wire • 07/11/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 10:05:56 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/09/2024 08:38:26 PM
- Know Labs to Present at the American Diabetes Association’s Scientific Sessions • Business Wire • 06/21/2024 10:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/17/2024 08:52:17 PM
- Know Labs Joins the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering at Harvard University • Business Wire • 06/05/2024 01:00:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 06/03/2024 06:11:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2024 08:15:29 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM